Upward Trends in Research, Funding and Commercialization

The University of Alaska Anchorage (UAA) is the largest university in the University of Alaska system. UAA's research and commercialization trends are upward. External funding research increased by 9.5% in FY12. Of the external funds, 46% were from federal sources, the majority of which from the National Institutes of Health (NIH) and the National Science Foundation (NSF).

To commercialize faculty and student research at UAA, the Vice Provost for Research and Graduate Studies created an agile business infrastructure. This infrastructure includes Seawolf Holdings, LLC and the Seawolf Venture Fund. Seawolf Holdings provides a corporate interface between UAA and enterprise companies and manages the companies, while the Seawolf Venture Fund provides seed money for early stage technology companies.

The number of invention disclosures increased to 29 since January 2012, in contrast to the three disclosures received in the previous year.

  • Of the 29 invention disclosures, many included students and two disclosures were from students alone.
  • Twelve disclosures evolved into patents pending, with more in process.

The technology sectors include:

  • Biomedical devices

  • Pharmaceutical therapeutics for neurodegenerative diseases (Alzheimer’s and Parkinson’s) and other diseases

  • No battery long lifespan wireless sensors for remote monitoring and surveillance

  • Educational software

  • Remotely controlled, low cost and embedded de-icing system using carbon nanofiber mats

  • Cybersecurity and education use

For a list of patents and patents pending at UAA, click here.

Research Commercialization in Action

 

UAA's new branding effort highlights patent-pending research developed on campus. UAA Engineers Anthony Paris, Jennifer Brock and John Lund developed an instrumented mouth guard with custom wireless capabilities that provides coaches and team physicians accurate assessments when athletes experience head injuries.